Europe Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Oth

Europe Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)

The Europe digital therapeutics market is expected to reach US$ 1,338.13 million by 2028 from US$ 1,023.59 million in 2021; it is estimated to grow at a CAGR of 22.9% from 2021 to 2028.

The growth of the market is attributed to the rising number of partnerships and collaborations by healthcare companies and the increasing number of start-ups across Europe. However, cyber threat and risk related to data security restrict the market growth.

Digital therapeutics has gained rapid acceptance from employers and insurance providers, owing to the benefits being offered by it. In support, there have been various significant collaborations and partnerships in the market, which have fueled the growth of digital therapeutics market. The market has a significant number of small players. However, large companies have begun to take interest in the market in the last few years. For instance, in June 2018, Cigna collaborated with Omada Health. Through this collaboration, eligible Cigna-administered health plan customers can have no-cost access to Omada’s digital intensive behavioral counseling platform as a fully covered preventive benefit in health improvement program portfolio. In 2019, Propeller Health, a leading digital therapeutics company, partnered with Orion Corporation to connect the latter’s Easyhaler line of inhalers for asthma and COPD patients to Propeller’s digital medicine platform. Propeller’s platform covers more than 90% of inhalable medicines for asthma and COPD. The partnership expanded Propeller’s presence in Europe. The association has actively driven the digital therapeutics industry's growth through collaborations and partnerships. In May 2018, DTA announced a partnership with USP, a nonprofit organization headquartered in Rockville, Maryland, to develop appropriate standards and guidelines for digital therapeutics. In October 2018, DTA expanded its European membership by joining S3 Connected Health, specialized in designing and developing digital therapeutics and health solutions.

Digital therapeutics help monitor and manage various chronic disorders, such as diabetes, heart disease, and respiratory infections. There have been various government initiatives that have supported the growth of the digital therapeutics market. Hence, government-aided reimbursements, surging approvals, increasing number of patients being monitored are expected to encourage startups to enter the digital therapeutics industry.

Europe Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)

Europe Digital Therapeutics Market Segmentation

By Application

Diabetes Cardiovascular Diseases Central Nervous System (CNS) Disease Respiratory Smoking Cessation Musculoskeletal Diseases Others

By End User

Patients Providers Payers Employers By Country

Germany UK France Italy Spain Rest of Europe Company Profiles

Propeller Health (Res Med) Noom, Inc Teladoc Health, Inc. Fitbit, Inc.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe digital therapeutics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe digital therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.